The 20 Best HER-2 Positive Breast Cancer Doctors Near Me in Bronx, NY

Francisco Esteva is an Oncologist practicing medicine in New York, New York. Dr. Esteva is rated as an Elite provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Esteva is board certified in American Board Of Internal Medicine/Medical Oncology.

My research is focused on breast cancer management, and on care delivery and support for breast cancer patients. Dr. Makower is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Pleuropulmonary Blastoma.

Keyur Mehta is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Mehta is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Breast Cancer, Neuroendocrine Carcinoma of the Cervix, and Vulvar Cancer.

Nitin Ohri, MD, MS, is Professor, Radiation Oncology at Montefiore Einstein. He is a radiation oncologist with a clinical focus on treating lung and gastrointestinal cancers. Dr. Ohri is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Nasopharyngeal Carcinoma.

Jana Fox is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Fox is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 38 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Throat Cancer, and Laryngeal Cancer.

Rafi Kabarriti, MD, is a cum laude graduate of Columbia University with a bachelor’s degree in biochemistry and economics. Dr. Kabarriti is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Laryngeal Cancer, Throat Cancer, Cervical Cancer, and Colonoscopy.

Justin Tang is a Radiation Oncologist practicing medicine in Bronx, New York. Dr. Tang is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Fibrolamellar Carcinoma, Prostate Cancer, Familial Prostate Cancer, and Cholangiocarcinoma (Bile Duct Cancer).

Dr. Mundi completed his medical degree at SUNY Downstate and finished his internal medicine residency at Boston University Medical Center. He completed training in medical oncology and hematology at Columbia University Medical Center and joined the faculty in 2016. Dr. Mundi's clinical interests include bone and soft tissue sarcomas and other rare cancers, and his research interests are in adapting bioinformatics and systems biology approaches in the laboratory to guide personalized therapeutics in the clinic. Dr. Mundi is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Rhabdoid Tumor, Neuroendocrine Tumor, Bone Tumor, and Alveolar Soft Part Sarcoma. Dr. Mundi is board certified in Internal Medicine. Dr. Mundi is currently accepting new patients.

Meghna S. Trivedi, MD, MS cares for patients diagnosed with breast cancer. Dr. Trivedi received her medical degree from the University of Maryland School of Medicine, and completed her residency at the University of Pennsylvania. She went on to complete her fellowship in hematology/oncology at Columbia University.Dr. Trivedi co-leads the Hereditary Breast and Ovarian Cancer Program, a comprehensive, multi-disciplinary initiative aimed at screening, preventing, diagnosing, and treating hereditary breast and ovarian cancer. This innovative program brings together the resources of a world-renowned academic institution, including cutting-edge genomic testing, clinical trials, and experts in hereditary cancers across different specialties.Dr. Trivedi’s research and care expertise also includes cancer genetics and genomics, precision medicine, and chemotherapy induced peripheral neuropathy. She is the principal investigator on several clinical trials, and has authored numerous publications in leading peer-reviewed journals. Dr. Trivedi is a member of the American Society of Clinical Oncologists and SWOG. Dr. Trivedi is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Salpingo-Oophorectomy, and Thrombectomy. Dr. Trivedi is board certified in Internal Medicine. Dr. Trivedi is currently accepting new patients.

Dr. Hershman is Witten Family Professor of Medicine, American Cancer Society Professor of Medicine and Epidemiology, chief of the division of hematology/oncology, and deputy director of the Herbert Irving Comprehensive Cancer Center at Columbia University. She completed her medical degree at the Albert Einstein College of Medicine, and completed her internal medicine and oncology fellowship training at Columbia University Medical Center, where she served as Chief Resident. During that time she completed a Master's degree in Biostatistics at the Mailman School of Public Health. She has developed nationally recognized expertise in breast cancer treatment, prevention, and survivorship.Dr. Hershman has also developed a comprehensive multidisciplinary program to study ways of improving cancer care delivery (CCD), reducing disparities and designing studies to improve the quality of life and quality of care in breast cancer survivors. She has received funding from the American Society of Clinical Oncology, American Cancer Society, Department of Defense, Breast Cancer Research Foundation, PCORI, and the National Cancer Institute. She currently has mentored numerous faculty members who have been granted mentored career development awards, and has received the Women Who Conquer Cancer Mentorship Award and the CUIMC Mentor of the Year Award. Dr. Hershman has published over 450 scientific articles and has received several awards including the highly prestigious Advanced Clinical Research Award in Breast Cancer from the American Society of Clinical Oncology, the Advanced Medical Achievement Award from the Avon Foundation and a Giants in Cancer Care Award.She has several national leadership roles in oncology. As vice chair of the SWOG Cancer Research Network she oversees the NCI's Community Oncology Research Programs (NCORP) research portfolio, which includes prevention and epidemiology, cancer care delivery, symptom control and quality of life, and survivorship trials. Within ASCO she was selected to participate in the first Leadership Development Program and has been the Chair of the Grants Selection Committee, Chair of the ASCO Quality Care Symposium and has been a member of multiple committees and task-forces. She is on the editorial board for the Journal of Clinical Oncology and is an Associate Editor at the Journal of the National Cancer Institute. Dr. Hershman is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Febrile Neutropenia, Inflammatory Breast Cancer, Vulvectomy, and Salpingo-Oophorectomy. Dr. Hershman is board certified in Internal Medicine and Medical Oncology. Dr. Hershman is currently accepting new patients.

Paul L. Baron, MD, is Chief of breast surgery and Director of the breast cancer program at Lenox Hill Hospital. An accomplished breast surgical oncologist, Dr. Baron specializes in high risk patients and oncoplastic surgery. His goals are to oversee the expansion and enhancement of the hospital s breast surgery services and it's multidisciplinary breast cancer program. The Breast Cancer Center of the Northwell Health Cancer Institute, is one of the largest oncology programs in the New York metro area.Throughout his career, Dr. Baron has actively engaged in advancing the field of oncology. He has published more than 120 articles and abstracts on various cancer-related topics and has been invited to speak at more than 60 national conferences. He has received more than $3.3 million in grant funding for medical research from such high-profile sources as the American Cancer Society and the Department of Defense and holds two patents in the area of cancer diagnosis and treatment. He is affiliated with numerous distinguished professional societies, including The American College of Surgeons, The Society of Surgical Oncology and The American Society of Breast Surgeons, where he serves on the board of directors. He also serves on the Board of Directors of the National Accreditation Program for Breast Centers (NAPBC).Dr. Baron earned both his undergraduate and medical degrees from Boston University's six-year medical program. He completed his internship and residency in general surgery at the Medical College of Virginia, where he served as chief surgery resident during his final year. He subsequently pursued a surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center and was honored with the American Cancer Society s Clinical Oncology Fellowship Award for his work. Dr. Baron is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Lymphadenectomy, and Mastectomy. Dr. Baron is board certified in American Board Of Surgery.

Melissa Accordino is an Oncologist practicing medicine in New York, New York. She has been practicing medicine for over 17 years. Dr. Accordino is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Hormone Replacement Therapy (HRT), and Endoscopy. Dr. Accordino is currently accepting new patients.

Katherine D. Crew, M.D., M.S. is an the Avon Products Foundation Professor of Medicine and Epidemiology at the NewYork-Presbyterian/Columbia University Medical Center, co-associate director for education and training and co-director of the Cancer Research Training and Education Core (CRTEC) at the Herbert Irving Comprehensive Cancer Center (HICCC). In addition to treating patients with breast cancer and women at high-risk for breast cancer, Dr. Crew has a long-standing interest and background in the design of clinical trials and observational studies in breast cancer prevention and survivorship.She serves as the Director of the Clinical Breast Cancer Prevention Program at Columbia University and Executive Officer for the SWOG Prevention, Screening, and Surveillance and Cancer Care Delivery Committees. She is a member of multiple national consortia and societies in oncology, including the American Association for Cancer Research and American Society of Clinical Oncology, and is an editorial board member of the Journal of Clinical Oncology. Dr. Crew received her undergraduate B.S. in Biochemistry from Brown University, where she graduated Magna Cum Laude. She received her M.D. from Columbia University College of Physicians and Surgeons and her M.S. from Columbia University School of Public Health. She completed her Internal Medicine residency and Medical Oncology fellowship at NewYork-Presbyterian/Columbia University Medical Center. Dr. Crew is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Salpingo-Oophorectomy. Dr. Crew is board certified in Internal Medicine and Medical Oncology. Dr. Crew is currently accepting new patients.

As an Assistant Professor of Medicine within the Division of Hematology/Oncology at Columbia University Irving Medical Center (CUIMC), Dr. McGuinness specializes in the care of patients with breast cancer or who are at high risk of developing breast cancer. She is currently involved in patient care, clinical research, and education. Her research interests include the evaluation of novel imaging-based tools to refine breast cancer risk prediction and to predict which patients receive benefit from breast cancer therapies. As part of this work, she collaborates closely with computer scientists, data scientists, and breast radiologists at Columbia. She also serves as the principal investigator for multiple clinical trials at CUIMC that evaluate novel treatments for patients with breast cancer. She is actively involved in the SWOG Cancer Research Network, and serves as a member of the SWOG Prevention and Epidemiology and Breast Committees, as well as the SWOG Breast Translational Medicine Working Group.Dr. McGuinness received her bachelor of arts in Biology magna cum laude from Williams College, and her medical degree with Honor from Baylor College of Medicine, where she was elected to the Gold Humanism Honor Society. She completed both her Internal Medicine residency and Hematology/Oncology fellowship at Columbia University Irving Medical Center, during which she also served as Chief Fellow and completed a Postdoctoral Research Fellowship in Biomedical Informatics. Dr. McGuinness is the recipient of multiple career development awards from the Conquer Cancer Foundation/American Society of Clinical Oncology and the Susan G. Komen Foundation, as well as a TRANSFORM KL2 Mentored Career Development Award. Dr. Mcguinness is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Paget Disease of the Breast, and HER-2 Positive Breast Cancer. Dr. Mcguinness is currently accepting new patients.

Dr. Bret Taback is a nationally recognized surgical oncologist in the New York-Presbyterian/Columbia University Irving Medical Center department of surgery. Dr. Taback is a leader in the clinical management of melanoma, sarcoma and skin/soft tissue tumor surgery. Dr. Taback is the Director of the Melanoma and Sarcoma Program and Director of the Breast Surgery Fellowship. Dr. Taback received his MD degree at Tufts University School of Medicine in Boston , and completed his general surgery residency at Brown University, Rhode Island Hospital. During that time he completed a Basic Science Research Fellowship at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston. Following this, he completed a fellowship in Complex Surgical Oncology at the John Wayne Cancer Institute, Santa Monica, California. Dr. Taback is a member of a number of organizations and societies including Society of Surgical Oncology, American Society of Clinical Oncology and the American Association for Cancer Research. He is also a Fellow of the American College of Surgeons. He has published and authored numerous peer review manuscripts, abstracts and presentations, as well as book chapters over the years in notable publications such as Annals of Surgery, Annals of Surgical Oncology, Cancer Research, Clinical Cancer Research and the Journal of the National Cancer Institute. He is a clinical investigator with SWOG and Alliance for clinical trials. Dr. Taback has served on numerous hospital committees including tumor boards, Institutional Review Boards, Oncology Operations Council and is the American College of Surgeon’s Commission on Cancer Physician Liaison for NYP Hospital. Most recently, Dr. Taback is a noted Castle Connolly Top Doctor. Dr. Taback is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Melanoma, Paget Disease of the Breast, Mastectomy, and Lymphadenectomy. Dr. Taback is board certified in Surgery. Dr. Taback is currently accepting new patients.

Lisa Wiechmann is a General Surgeon practicing medicine in New York, New York. Dr. Wiechmann is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Lymphadenectomy, and Mastectomy. Dr. Wiechmann is board certified in Surgery. Dr. Wiechmann is currently accepting new patients.

Amy Tiersten is an Oncologist practicing medicine in New York, New York. Dr. Tiersten is rated as a Distinguished provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Angiosarcoma. Dr. Tiersten is currently accepting new patients.

Brenda Panzera is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Panzera is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Blood Clots, Breast Cancer, Paget Disease of the Breast, and Anemia. Dr. Panzera is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Malvina Fulman, MD, is a medical oncologist and hematologist with an interest in breast cancer. She practices at Northwell Health Cancer Institute Queens Medical Associates, a group of eight oncologists and a palliative care doctor. The doctors and staff within this group speak more than 10 languages, which helps them to accommodate the cultural diversity of Queens. Dr. Fulman speaks Russian, Georgian and English.The idea behind our group is to help our patients in the best possible way, Dr. Fulman says. It's much easier when you can relate to your doctor in the same language. We understand not only the medical part. We also understand the cultural part, so we can address those issues as well.Dr. Fulman was inspired to become a doctor after an aunt died of breast cancer when Dr. Fulman was 14. You want to help your family and to help other people as well, she says.After finishing her medical education at Tbilisi State Medical Institute in Georgia, she completed an internship at Republican Hospital in Tbilisi, Georgia, and a residency and fellowship at Cabrini Medical Center/ Mount Sinai School of Medicine.Dr. Fulman is board certified in medical oncology and hematology. She is also a Fellow of the American College of Physicians and belongs to the American Society of Clinical Oncology, and she has a teaching appointment at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.One of the best parts of Dr. Fulman's job is seeing her patients reach milestones with their families graduations, weddings, and anniversaries. I enjoy when I go to work and see patients who came to me five, 10, 15, 20 years ago, and they're still around and they're still okay, Dr. Fulman says. It's really special. Dr. Fulman is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Childhood Iron Deficiency Anemia. Dr. Fulman is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Anupama Goel is an Oncologist practicing medicine in New York, New York. Dr. Goel is rated as a Distinguished provider by MediFind in the treatment of HER-2 Positive Breast Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Breast Cancer in Men, Paget Disease of the Breast, and HER-2 Positive Breast Cancer. Dr. Goel is currently accepting new patients.